Probiosis-5

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Saccharomyces cerevisiae (Boulardii), Quantity: 5 billion CFU; Lactobacillus gasseri, Quantity: 2 billion CFU; Lactobacillus reuteri, Quantity: 3 billion CFU; Bifidobacterium breve, Quantity: 5 billion CFU; Lactobacillus rhamnosus, Quantity: 5 billion CFU

Disponible des:

Spectrumceuticals Pty Ltd

Designació comuna internacional (DCI):

Bifidobacterium breve,Lactobacillus gasseri,Lactobacillus reuteri,Lactobacillus rhamnosus,Saccharomyces cerevisiae (Boulardii)

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified water

Vía de administración:

Oral

indicaciones terapéuticas:

Maintain/support general health and wellbeing ; Maintain/support intestinal health ; Maintain/support intestinal good/beneficial/friendly flora ; Maintain/support small intestine good/beneficial/friendly flora ; Maintain/support gastrointestinal system health ; Maintain/support gastrointestinal mucosal membrane health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support healthy gastrointestinal immune function

Resumen del producto:

Visual Identification: ;

Estat d'Autorització:

Licence status A

Data d'autorització:

2017-09-13